Bay Harbor Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Bay Harbor Wealth Management, LLC
- $347 Million
- Q3 2025
A detailed history of Bay Harbor Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bay Harbor Wealth Management, LLC holds 68 shares of GILD stock, worth $8,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68
Previous 55
23.64%
Holding current value
$8,438
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
2,386Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...